Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$752K Sell
28,572
-140,762
-83% -$3.55M ﹤0.01% 2351
2026
Q1
$4.3M Buy
169,334
+5,799
+4% +$150K 0.01% 1098
2025
Q4
$3.55M Buy
163,535
+1,388
+0.9% +$28.5K 0.01% 957
2025
Q3
$3.3M Buy
162,147
+69,532
+75% +$1.43M 0.01% 877
2025
Q2
$1.81M Buy
+92,615
New +$1.61M 0.01% 969
2024
Q4
Sell
-55,204
Closed -$1.09M 2990
2024
Q3
$1.09M Buy
+55,204
New +$961K 0.01% 1197
2023
Q3
Sell
-51,774
Closed -$1.75M 2882
2023
Q2
$1.75M Buy
+51,774
New +$1.83M 0.02% 665
2022
Q4
Sell
-25,723
Closed -$843K 2931
2022
Q3
$843K Buy
+25,723
New +$975K 0.01% 1044
2021
Q2
Sell
-21,026
Closed -$857K 3315
2021
Q1
$857K Buy
+21,026
New +$801K 0.01% 1294
2020
Q4
Sell
-44,988
Closed -$1.11M 2273
2020
Q3
$1.11M Buy
+44,988
New +$1.04M 0.03% 466

Other funds holding NVST

HRT Financial's NVST Position: Q2 2026 in Review

HRT Financial reduced its Envista (NVST) stake by 83% in Q2 2026, selling an estimated $3.55M and leaving 28,572 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

HRT Financial first reported a position in NVST in Q3 2020 and has held it in 10 quarters since. The position peaked at $4.3M in Q1 2026. 382 funds tracked by Wall St. Rank hold NVST as of Q2 2026.

  • HRT Financial held 28,572 shares of Envista worth $752K as of Q2 2026.
  • HRT Financial sold 140,762 Envista shares in Q2 2026, an estimated $3.55M.
  • Envista made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2351 holding.
  • HRT Financial first reported a position in Envista in Q3 2020 and has held it in 10 quarters since.
  • HRT Financial's Envista position peaked at $4.3M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held Envista as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.